| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/27/2008 | EP1960364A2 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 08/27/2008 | EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 08/27/2008 | EP1960362A1 Process for making montelukast and intermediates therefor |
| 08/27/2008 | EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
| 08/27/2008 | EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 08/27/2008 | EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors |
| 08/27/2008 | CN101253147A Organic compounds |
| 08/27/2008 | CN101252928A Quinoline derivatives as antibacterial agents |
| 08/27/2008 | CN101252927A Quinoline derivatives as antibacterial agents |
| 08/26/2008 | US7417149 Reacting, reaction product of 1-(mercaptomethyl)cyclopropaneacetic acid and lithium hexamethyldisilazide, with Methyl [S-(E)]-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-methanesulfonyloxy-propyl]benzoate by nucleophicl substitution reaction to yield intermediates, methylation to form montelukast |
| 08/26/2008 | US7417148 Enzyme inhibitors for treatment of cancer leukemia |
| 08/26/2008 | US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
| 08/21/2008 | WO2008099221A1 Amide and urea derivatives for the treatment of metabolic diseases |
| 08/21/2008 | WO2008098965A1 Process for obtaining montelukast |
| 08/21/2008 | WO2008081096A3 Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents |
| 08/21/2008 | US20080200683 Process for Preparing (Alpha S, Beta R)-6-Bromo-Alpha-[2-(Dimethylamino) Ethyl]-2-Methoxy-Alpha-1-Naphthalenyl-Beta-Phenyl-3-Quinolineethanol |
| 08/21/2008 | US20080200533 Creating modified complex molecules having reduced toxicity and enhanced bioavailability; such as reaction product of atorvastatin and 2,6-diaminohexanoic acid; increasing solubility; reducing dosage levels |
| 08/21/2008 | US20080200504 non-peptide NK-3 receptor ligands; anxiety, depression, schizophrenia, obesity; 2-Phenyl-quinoline-4-carboxylic acid (1-pyridin-4-yl-propyl) amide; reacting the 2-phenyl-quinolinyl-4-carbonyl chloride with a pyridylalkylamine to form the amide |
| 08/21/2008 | US20080200500 Quinoline Derivatives as Nk3 Antagonists |
| 08/21/2008 | US20080200459 Tetrahydroquinoline cannabinoid receptor modulators |
| 08/21/2008 | US20080200451 Antitumor agents; use in combination with other drugs such as pentamidine |
| 08/21/2008 | US20080199875 Unsymmetrical cyanine dimer compounds and their application |
| 08/20/2008 | EP1958936A1 Process for obtaining montelukast |
| 08/20/2008 | EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1778624B1 Tyrosine derivatives as ppar-gamma-modulators |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN101248047A Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| 08/20/2008 | CN101247877A Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 08/20/2008 | CN101247811A Quinoline derivatives as antibacterial agents |
| 08/20/2008 | CN101247722A Biphenyl-N- (4-pyridyl) methylsulfonamides |
| 08/20/2008 | CN100412075C Process for preparing L-ofloxacin and ofloxacin |
| 08/20/2008 | CN100412062C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/19/2008 | CA2207185C Carbostyril derivatives as antithrombotic agents |
| 08/14/2008 | WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 08/14/2008 | WO2008096127A2 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators |
| 08/14/2008 | WO2008095720A1 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 08/14/2008 | WO2008011513A3 Compounds and methods of modulating angiogenesis |
| 08/14/2008 | US20080194825 Process for obtaining montelukast |
| 08/14/2008 | US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 08/14/2008 | US20080194624 Drug for Alzheimer's disease; cognition activators; strokes; down's disease; Parkinson's disease |
| 08/14/2008 | US20080194623 Reacting chemical intermediate quinoline compound with carbonyldiimidazole |
| 08/14/2008 | US20080194622 Antidepressants; anxiolytic agents;schizophrenia; cognition activators |
| 08/14/2008 | US20080194609 Chemical Compound and Its Use |
| 08/14/2008 | US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these |
| 08/14/2008 | CA2677610A1 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the .beta.2 adrenergic receptor |
| 08/13/2008 | EP1956028A2 Photolabile compound, oligomer probe array and substrate for oligomer probe array containing the same, and manufacturing method of the same |
| 08/13/2008 | EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands |
| 08/13/2008 | EP1955996A1 7, 9-Substituted tetracycline compounds |
| 08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
| 08/13/2008 | EP1954689A1 N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same |
| 08/13/2008 | EP1954679A1 A new intermediate for making montelukast and related compounds |
| 08/13/2008 | EP1954274A2 Substituted quinolones and methods of use |
| 08/13/2008 | EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/13/2008 | EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis |
| 08/13/2008 | EP1753723B1 Substituted quinoline derivatives as mitotic kinesin inhibitors |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1368305B1 7, 9-substituted tetracycline compounds |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | CN101239946A Method for preparing decoquinate premix |
| 08/13/2008 | CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 08/13/2008 | CN100410243C Process for preparing quinolone pharmaceutical intermediates |
| 08/12/2008 | US7411068 Luminescent compounds |
| 08/12/2008 | US7411067 Crystalline forms of gatifloxacin |
| 08/07/2008 | WO2008093855A1 Composition for treatment of undifferentiated-type of gastric cancer |
| 08/07/2008 | WO2008093742A1 Process for production of binuclear metal complex |
| 08/07/2008 | WO2008093188A1 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride |
| 08/07/2008 | WO2008092576A1 Enrofloxacin-hexahydrate |
| 08/07/2008 | US20080188664 Process for preparing montelukast sodium containing controlled levels of impurities |
| 08/07/2008 | US20080188658 Novel synthesis of gatifloxacin |
| 08/07/2008 | US20080188655 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188520 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; potassium channel KACh and TASK-1 channel blocking agent; atrial arrhythmias, atrial fibrillation or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent |
| 08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine |
| 08/07/2008 | DE102007004732A1 Enrofloxacin-Hexahydrat Enrofloxacin hexahydrate |
| 08/07/2008 | CA2676849A1 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride |
| 08/07/2008 | CA2676796A1 Composition for treatment of undifferentiated gastric cancer |
| 08/07/2008 | CA2676698A1 Enrofloxacin-hexahydrate |
| 08/06/2008 | EP1953152A1 Process for preparing quinazoline RHO-kinase inhibitors and intermediates thereof |
| 08/06/2008 | EP1953143A1 Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
| 08/06/2008 | EP1951656A1 Histone deacetylase inhibitors as therapeutics for neurological diseases |
| 08/06/2008 | EP1532113B1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | CN101238110A Heterocyclic compounds as agonists for the thyroid receptor |
| 08/06/2008 | CN101238105A Aripiprazole salts |
| 08/06/2008 | CN100408562C Method of producing ethyl (3r, 5s, 6e)-7-[2 cyclopropyl-4-(fluorophenyl) quinoline-3-yl]-3, 5-dihydroxy-6-heptenoate |
| 08/05/2008 | US7408065 P2X7 receptor antagonists and their use |
| 08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/05/2008 | CA2153984C Process for the manufacture of a tricyclic compound |
| 07/31/2008 | WO2008091752A2 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 07/31/2008 | WO2008090434A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 07/31/2008 | US20080182988 Reaction product of aripiprazole with methanol |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182875 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide |